EM

Eldad Melamed

RU Ramot At Tel-Aviv University: 14 patents #19 of 1,095Top 2%
BT Brainstorm Cell Therapeutics: 5 patents #1 of 12Top 9%
TI Teva Pharmaceutical Industries: 4 patents #97 of 489Top 20%
MA Mor Research Applications: 3 patents #10 of 167Top 6%
UN Unknown: 2 patents #12,644 of 83,584Top 20%
YC Yeda Research And Development Co.: 2 patents #328 of 1,403Top 25%
NT Nst Neurosurvival Technologies: 1 patents #4 of 6Top 70%
IN Inuitive: 1 patents #11 of 26Top 45%
CD Ceva D.S.P.: 1 patents #18 of 45Top 40%
Overall (All Time): #161,074 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Showing 1–25 of 25 patents

Patent #TitleCo-InventorsDate
12067791 Method and system for roads' maintenance 2024-08-20
11185572 Mesenchymal stem cells for the treatment of CNS diseases Avinoam Kadouri, Avihay Bar-Ilan, Daniel Offen, Ofer Sadan, Merav Bahat-Stromza 2021-11-30
10869899 Isolated cells and populations comprising same for the treatment of CNS diseases Daniel Offen, Merav Bahat-Stromza 2020-12-22
10744162 Genetically modified muscle cells which express neurotrophic factors Daniel Offen, Michal Dadon-Nachum, Tali Ben-Zur, David Yaffe 2020-08-18
10052363 Mesenchymal stem cells for the treatment of CNS diseases Avinoam Kadouri, Avihay Bar-Ilan, Daniel Offen, Ofer Sadan, Merav Bahat-Stromza 2018-08-21
9879225 Isolated cells and populations comprising same for the treatment of CNS diseases Daniel Offen, Merav Bahat-Stromza 2018-01-30
9717761 Stem cell-derived neural cells for cell therapy in neurological disorders Sandu Pitaru, Javier Ganz, Daniel Offen 2017-08-01
9474787 Mesenchymal stem cells for the treatment of CNS diseases Avinoam Kadouri, Avihay Bar-Ilan, Daniel Offen, Ofer Sadan, Merav Bahat-Stromza 2016-10-25
9365828 Genetically modified muscle cells which express neurotrophic factors Daniel Offen, Michal Dadon-Nachum, Tali Ben-Zur, David Yaffe 2016-06-14
9023800 Peptides for the treatment of oxidative stress related disorders Daniel Offen, Nirit Lev 2015-05-05
8900574 Mesenchymal stem cells for the treatment of CNS diseases Avinoam Kadouri, Avihay Bar-Ilan, Daniel Offen, Ofer Sadan, Merav Bahat-Stromza 2014-12-02
8663987 Mesenchymal stem cells for the treatment of CNS diseases Avinoam Kadouri, Avihay Bar-Ilan, Daniel Offen, Ofer Sadan, Merav Bahat-Stromza 2014-03-04
8647874 Isolated cells and populations comprising same for the treatment of CNS diseases Daniel Offen, Merav Bahat-Stromza 2014-02-11
8378070 Peptides for the regulation of neurotransmitter sequestration and release Nirit Lev, Daniel Offen 2013-02-19
8212001 Peptides for the treatment of oxidative stress related disorders Daniel Offen, Nirit Lev 2012-07-03
8213502 Method and system for real-time adaptive quantization control Roni M. Sadeh, Erez Barniv 2012-07-03
7280594 Method and apparatus for motion estimation in a sequence of digital images Yaron M. Sadeh 2007-10-09
6420429 Brain targeted low molecular weight hydrophobic antioxidant compounds Daphne Atlas, Daniel Offen 2002-07-16
6417210 Treatment of dyskinesias and Parkinson's disease with riluzole and levodopa Ruth Djaldetti, Ilan Ziv 2002-07-09
6369106 Treatment of ischemic brain injuries with brain targeted anti oxidant compounds Daphne Atlas, Daniel Offen 2002-04-09
5874468 Brain targeted low molecular weight hydrophobic antioxidant compounds Daphne Atlas, Daniel Ofen 1999-02-23
5840756 Pharmaceutical composition of L-DOPA ester Sasson Cohen, Sela Yoram, Ruth Levy, Nava Shterman, Dafna Atlas 1998-11-24
5607969 L-DOPA ethyl ester to treat Parkinson's disease Isaac Milman, Alexander Veinberg, Daphne Atlas 1997-03-04
5525631 Compositions of the ethyl ester of L-DOPA Isaac Milman, Alexander Veinberg, Daphne Atlas 1996-06-11
5354885 Process for preparing ethyl ester of L-DOPA Isaac Milman, Alexander Veinberg, Daphne Atlas 1994-10-11